Optimizing topical management of atopic dermatitis.

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Background:

• Atopic dermatitis (eczema) is a chronic inflammatory skin condition affecting all ages.
• Management traditionally relies on topical therapies, but challenges remain in optimizing treatment and preventing flares.

Purpose of the Study:

• To review current atopic dermatitis management strategies.
• To focus on optimizing topical therapy and establishing a stepwise treatment approach.
• To provide guidance on initiating systemic therapy when needed.

Main Methods:

• A PubMed search was conducted for English-language articles on atopic dermatitis.
• Relevant articles across all age groups were selected and reviewed.

Main Results:

• Topical corticosteroids remain first-line, with nonsteroidal options available for sensitive sites and to reduce corticosteroid use.
• Proactive topical management can maintain control of localized dermatitis.
• If topical therapy fails, reevaluation and optimization are crucial before considering systemic agents.
• Dupilumab (an interleukin-4 receptor inhibitor) is a first-line systemic therapy due to its efficacy and safety profile.
• Emerging biologics and Janus kinase inhibitors offer alternatives to traditional immunosuppressants.

Conclusions:

• Multiple topical treatment options exist, necessitating a stepwise approach.
• Considering alternative therapies and diagnoses is vital before systemic treatment.
• The safety of novel immunomodulators may lower the threshold for more aggressive interventions.